February 8, 2019 Sweeping Proposed Rule on Rebate Safe Harbor has Potential to Impact all Drug Supply Chain Stakeholders
February 6, 2019 New FDA Proposed Rule Looking to Define the Term “Biological Product” Seeks Comments
February 4, 2019 Comments Wanted: New ICER Report to Assess if Clinical Evidence Exists for Significant Increase in Prescription Drug Prices
February 1, 2019 Take Action: New CMS Proposed Rule Targeting Manufacturers, Patient Assistance Programs, ACOs, Payers and ACA Exchange Stakeholders
January 23, 2019 CMS Permits Use of Step Therapy for Part B Drugs with Medicare Advantage Plans Affecting Physician Dispensing and Specialty Pharmacy Patients
January 16, 2019 Modifying HIPAA Rules: OCR Looks for Input from Physicians, Hospitals and Healthcare Stakeholders
January 14, 2019 Growing Trend Toward PBM Transparency Provides Opportunities for State Medicaid Directors
January 10, 2019 Take Action: Pharmacy Industry Asked to Comment on the New CMS Proposed Rule Aimed at DIR Fees
December 20, 2018 State and Pharmacy Associations Can Demand Greater Conditions of Approval from Agencies that Oversee PBM and Insurer Mergers
December 14, 2018 What You Need to Know: The HHS “Reforming America’s Healthcare System Through Choice and Competition” Report
